Pharmafile Logo
Pharmafocus logo
Advanced Search

Afinitor

Showing 15 posts of 36 posts found.

AZ image

AstraZeneca diabetes drug approved for use in Scotland

November 11, 2014
Sales and Marketing Afinitor, AstraZeneca, Eylea, Onglyza, Perjeta, SMC, diabetes, type 2

The Scottish Medicines Consortium (SMC) has shown AstraZeneca’s Onglyza (saxagliptin) the green light to be used with insulin in patients …

News

Novartis reports healthy profit

April 25, 2014
Sales and Marketing Afinitor, Gleevec, Glivec, Novartis, Q1, lilly

Multiple sclerosis drug Gilenya and cancer treatment Afinitor were among the biggest sellers for Novartis, as the Swiss company’s net …

News
Novartis image

Novartis sees profit slip

October 23, 2013
Sales and Marketing Afinitor, Diovan, Novartis, Q3, gilenya

Novartis saw generic competition erode profit in the third quarter of the year, although sales across the group actually rose …

News

Afinitor too costly for NICE despite price cut

August 29, 2013
Sales and Marketing Afinitor, HER2 negative, NICE, Novartis, breast cancer

News
Afinitor image

Late-stage failure for Afinitor

August 8, 2013
Research and Development, Sales and Marketing Afinitor, Cancer, Novartis, liver

Novartis’ oncology programme has received a blow with the news that Afinitor has failed to help patients live longer in …

News
Afinitor iimage

Novartis’ Afinitor fails NICE test

July 8, 2013
Sales and Marketing Afinitor, NHS, NICE, Novartis

Novartis’ breast cancer drug Afinitor (everolimus) has been knocked back by NICE as “it is not good value for money”. …

News
Afinitor image

Afinitor’s new UK indication launched

September 20, 2012
Sales and Marketing Afinitor, CHMP, Novartis, breast cancer

Novartis’ cancer drug Afinitor has been made available in the UK for patients with the most common form of advanced …

News

Afinitor recommended in Europe for breast cancer

June 22, 2012
Sales and Marketing Afinitor, CHMP, Cancer, Novartis, breast

A European committee is recommending Novartis’ Afinitor to treat women with a certain type of breast cancer. The CHMP says …

News
Breast cancer image

Breast cancer treatment – the next advances

February 7, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Afinitor, CDF, Lorena Tonarelli, T-DM1, breast cancer, pertuzumab

When a close member of my family was diagnosed with breast cancer, the doctors didn’t give us much hope. They …

Feature
Novartis

Novartis’ brain tumour drug Votubia launched in UK

September 29, 2011
Sales and Marketing Afinitor, Votubia

Novartis has launched its orphan drug Votubia in the UK for patients with a rare type of brain tumour. Votubia …

News
Novartis Afinitor

Afinitor expands European licence

September 5, 2011
Sales and Marketing Afinitor, Novartis, Pancreatic cancer

Novartis’ Afinitor has made further strides in the EU with an approval for use in patients with advanced pancreatic neuroendocrine …

News

Afinitor poised to realise blockbuster ambitions?

July 25, 2011
Sales and Marketing Afinitor, Cancer, Novartis

Novartis’ Afinitor may be set to make good on its blockbuster promise after receiving European backing for its second licence …

News
Novartis Afinitor (everolimus)

Afinitor stops tumour growth in advanced breast cancer

July 5, 2011
Manufacturing and Production, Research and Development Afinitor, Novartis, Votubia, advanced breast cancer

Novartis’ Afinitor has impressed in a late-stage trial by increasing survival in women with advanced breast cancer. The phase III …

News
Novartis' Afinitor (everolimus)

Novartis’ Afinitor wins landmark US approval

May 6, 2011
Sales and Marketing Afinitor, Novartis

Novartis’ Afinitor has been approved in the US for the treatment of progressive neuroendocrine tumours of pancreatic origin (PNET) in …

News
Novartis' Afinitor (everolimus)

NICE unimpressed with Novartis’ patient access scheme

April 19, 2011
Sales and Marketing Afinitor, Kidney cancer, NICE, Novartis

Novartis has been dealt a blow by NICE after the cost-effectiveness body finally refused to recommend, on appeal, its kidney …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025